Mismatch negativity and P3a/reorienting complex in subjects with schizophrenia or at-risk mental state

Frontiers in Behavioral Neuroscience

Volumn 8, Issue MAY, 2014, Pages

  Higuchi, Yuko ^a   Seo, Tomonori ^a   Miyanishi, Tomohiro ^a   Kawasaki, Yasuhiro ^b   Suzuki, Michio ^a   Sumiyoshi, Tomiki ^c  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

Event related potentials; Mismatch negativity; Prodromal; Reorienting negativity; Schizophrenia

Indexed keywords

ADULT; ARTICLE; AT RISK MENTAL STATE; CONTROLLED STUDY; DISEASE COURSE; ELECTRODE; ELECTROENCEPHALOGRAM; EVENT RELATED POTENTIAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MISMATCH NEGATIVITY; NERVOUS SYSTEM PARAMETERS; P3A REORIENTING COMPLEX; REORIENTING NEGATIVITY; SCHIZOPHRENIA;

EID: 84901354477     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2014.00172     Document Type: Article

References (58)

1. Andreasen, N. C. (1990). Methods for assessing positive and negative symptoms. Mod. Probl. Pharmacopsychiatry 24, 73-88.
2. Atkinson, R. J., Michie, P. T., and Schall, U. (2012). Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis. Biol. Psychiatry 71, 98-104. doi: 10.1016/j.biopsych.2011.08.023
3. Berti, S., Roeber, U., and Schroger, E. (2004). Bottom-up influences on working memory: behavioral and electrophysiological distraction varies with distractor strength. Exp. Psychol. 51, 249-257. doi:10.1027/1618-3169.51.4.249
4. Bodatsch, M., Ruhrmann, S., Wagner, M., Muller, R., Schultze-Lutter, F., Frommann, I., et al. (2011). Prediction of psychosis by mismatch negativity. Biol. Psychiatry 69, 959-966. doi:10.1016/j.biopsych.2010.09.057
5. Broome, M. R., Woolley, J. B., Johns, L. C., Valmaggia, L. R., Tabraham, P., Gafoor, R., et al. (2005). Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state. Eur. Psychiatry 20, 372-378. doi:10.1016/j.eurpsy.2005.03.001
6. Bruder, G. E., Tenke, C. E., Towey, J. P., Leite, P., Fong, R., Stewart, J. E., et al. (1998). Brain ERPs of depressed patients to complex tones in an oddball task: relation of reduced P3 asymmetry to physical anhedonia. Psychophysiology 35, 54-63. doi:10.1111/1469-8986.3510054
7. Chang, W. C., Hui, C. L., Tang, J. Y., Wong, G. H., Lam, M. M., Chan, S. K., et al. (2011). Persistent negative symptoms in first-episode schizophrenia: a prospective three-year follow-up study. Schizophr. Res. 133, 22-28. doi:10.1016/j.schres.2011.09.006
8. Edwards, J., McGorry, P. D., Waddell, F. M., and Harrigan, S. M. (1999). Enduring negative symptoms in first-episode psychosis: comparison of six methods using follow-up data. Schizophr. Res. 40, 147-158. doi:10.1016/S0920-9964(99)00043-2
9. Friedman, D., Cycowicz, Y. M., and Gaeta, H. (2001). The novelty P3: an event-related brain potential (ERP) sign of the brain's evaluation of novelty. Neurosci. Biobehav. Rev. 25, 355-373. doi:10.1016/S0149-7634(01)00019-7
10. Galderisi, S., Mucci, A., Bitter, I., Libiger, J., Bucci, P., Wolfgang Fleischhacker, W., et al. (2012). Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial. Eur. Neuropsychopharmacol. 23, 196-204. doi:10.1016/j.euroneuro.2012.04.019
11. Green, M. F. (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry 153, 321-330.
12. Harvey, P. D., Green, M. F., Keefe, R. S., and Velligan, D. I. (2004). Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness. J. Clin. Psychiatry 65, 361-372. doi:10.4088/JCP.v65n0312
13. Heinrichs, R. W., and Zakzanis, K. K. (1998). Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12, 426-445. doi:10.1037/0894-4105.12.3.426
14. Higuchi, Y., Sumiyoshi, T., Ito, T., and Suzuki, M. (2013a). Perospirone normalized P300 and cognitive function in a case of early psychosis. J. Clin. Psychopharmacol. 33, 263-266. doi:10.1097/JCP.0b013e318287c527
15. Higuchi, Y., Sumiyoshi, T., Seo, T., Miyanishi, T., Kawasaki, Y., and Suzuki, M. (2013b). Mismatch negativity and cognitive performance for the prediction of psychosis in subjects with at-risk mental state. PLoS ONE 8:e54080. doi:10.1371/journal.pone.0054080
16. Higuchi, Y., Sumiyoshi, T., Kawasaki, Y., Ito, T., Seo, T., and Suzuki, M. (2010). Effect of tandospirone on mismatch negativity and cognitive performance in schizophrenia: a case report. J. Clin. Psychopharmacol. 30, 732-734. doi:10.1097/JCP.0b013e3181faa57d
17. Higuchi, Y., Sumiyoshi, T., Kawasaki, Y., Matsui, M., Arai, H., and Kurachi, M. (2008). Electrophysiological basis for the ability of olanzapine to improve verbal memory and functional outcome in patients with schizophrenia: a LORETA analysis of P300. Schizophr. Res. 101, 320-330. doi:10.1016/j.schres.2008.01.020
18. Horvath, J., Winkler, I., and Bendixen, A. (2008). Do N1/MMN, P3a, and RON form a strongly coupled chain reflecting the three stages of auditory distraction? Biol. Psychol. 79, 139-147. doi:10.1016/j.biopsycho.2008.04.001
19. Ikezawa, S., Nakagome, K., Mimura, M., Shinoda, J., Itoh, K., Homma, I., et al. (2008). Gender differences in lateralization of mismatch negativity in dichotic listening tasks. Int. J. Psychophysiol. 68, 41-50. doi:10.1016/j.ijpsycho.2008.01.006
20. International Early Psychosis Association Writing Group. (2005). International clinical practice guidelines for early psychosis. Br. J. Psychiatry Suppl. 48, s120-s124. doi:10.1192/bjp.187.48.s120
21. Itoh, T., Sumiyoshi, T., Higuchi, Y., Suzuki, M., and Kawasaki, Y. (2011). LORETA analysis of three-dimensional distribution of delta band activity in schizophrenia: relation to negative symptoms. Neurosci. Res. 70, 442-448. doi:10.1016/j.neures.2011.05.003
22. Jahshan, C., Cadenhead, K. S., Rissling, A. J., Kirihara, K., Braff, D. L., and Light, G. A. (2012). Automatic sensory information processing abnormalities across the illness course of schizophrenia. Psychol. Med. 42, 85-97. doi:10.1017/S0033291711001061
23. Kasai, K., Yamada, H., Kamio, S., Nakagome, K., Iwanami, A., Fukuda, M., et al. (2002). Do high or low doses of anxiolytics and hypnotics affect mismatch negativity in schizophrenic subjects? An EEG and MEG study. Clin. Neurophysiol. 113, 141-150. doi:10.1016/S1388-2457(01)00710-6
24. Kawasaki, Y., Maeda, Y., Higashima, M., Nagasawa, T., Koshino, Y., Suzuki, M., et al. (1997). Reduced auditory P300 amplitude, medial temporal volume reduction and psychopathology in schizophrenia. Schizophr. Res. 26, 107-115. doi:10.1016/S0920-9964(97)00055-8
25. Kawasaki, Y., Sumiyoshi, T., Higuchi, Y., Ito, T., Takeuchi, M., and Kurachi, M. (2007a). Voxel-based analysis of P300 electrophysiological topography associated with positive and negative symptoms of schizophrenia. Schizophr. Res. 94, 164-171. doi:10.1016/j.schres.2007.04.015
26. Kawasaki, Y., Suzuki, M., Kherif, F., Takahashi, T., Zhou, S. Y., Nakamura, K., et al. (2007b). Multivariate voxel-based morphometry successfully differentiates schizophrenia patients from healthy controls. Neuroimage 34, 235-242. doi:10.1016/j.neuroimage.2006.08.018
27. Kiang, M., Braff, D. L., Sprock, J., and Light, G. A. (2009). The relationship between preattentive sensory processing deficits and age in schizophrenia patients. Clin. Neurophysiol. 120, 1949-1957. doi:10.1016/j.clinph.2009.08.019
28. Leung, S., Croft, R. J., Baldeweg, T., and Nathan, P. J. (2007). Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects. Psychopharmacology (Berl.) 194, 443-451. doi:10.1007/s00213-007-0865-1
29. Lin, Y. T., Liu, C. M., Chiu, M. J., Liu, C. C., Chien, Y. L., Hwang, T. J., et al. (2012). Differentiation of schizophrenia patients from healthy subjects by mismatch negativity and neuropsychological tests. PLoS ONE 7:e34454. doi:10.1371/journal.pone.0034454
30. Loebel, A. D., Lieberman, J. A., Alvir, J. M., Mayerhoff, D. I., Geisler, S. H., and Szymanski, S. R. (1992). Duration of psychosis and outcome in first-episode schizophrenia. Am. J. Psychiatry 149, 1183-1188.
31. Malla, A. K., Norman, R. M., Takhar, J., Manchanda, R., Townsend, L., Scholten, D., et al. (2004). Can patients at risk for persistent negative symptoms be identified during their first episode of psychosis? J. Nerv. Ment. Dis. 192, 455-463. doi:10.1097/01.nmd.0000131804.34977.c1
32. Matsubayashi, J., Kawakubo, Y., Suga, M., Takei, Y., Kumano, S., Fukuda, M., et al. (2008). The influence of gender and personality traits on individual difference in auditory mismatch: a magnetoencephalographic (MMNm) study. Brain Res. 1236, 159-165. doi:10.1016/j.brainres.2008.07.120
33. McGorry, P. D., Nelson, B., Amminger, G. P., Bechdolf, A., Francey, S. M., Berger, G., et al. (2009). Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J. Clin. Psychiatry 70, 1206-1212. doi:10.4088/JCP.08r04472
34. Melle, I., Larsen, T. K., Haahr, U., Friis, S., Johannesen, J. O., Opjordsmoen, S., et al. (2008). Prevention of negative symptom psychopathologies in first-episode schizophrenia: two-year effects of reducing the duration of untreated psychosis. Arch. Gen. Psychiatry 65, 634-640. doi:10.1001/archpsyc.65.6.634
35. Mondragon-Maya, A., Solis-Vivanco, R., Leon-Ortiz, P., Rodriguez-Agudelo, Y., Yanez-Tellez, G., Bernal-Hernandez, J., et al. (2013). Reduced P3a amplitudes in antipsychotic naive first-episode psychosis patients and individuals at clinical high-risk for psychosis. J. Psychiatr. Res. 47, 755-761. doi:10.1016/j.jpsychires.2012.12.017
36. Naatanen, R., Kujala, T., Escera, C., Baldeweg, T., Kreegipuu, K., Carlson, S., et al. (2012). The mismatch negativity (MMN)-a unique window to disturbed central auditory processing in ageing and different clinical conditions. Clin. Neurophysiol. 123, 424-458. doi:10.1016/j.clinph.2011.09.020
37. Naatanen, R., Paavilainen, P., Rinne, T., and Alho, K. (2007). The mismatch negativity (MMN) in basic research of central auditory processing: a review. Clin. Neurophysiol. 118, 2544-2590. doi:10.1016/j.clinph.2007.04.026
38. Nagai, T., Tada, M., Kirihara, K., Yahata, N., Hashimoto, R., Araki, T., et al. (2013). Auditory mismatch negativity and P3a in response to duration and frequency changes in the early stages of psychosis. Schizophr. Res. 150, 547-554. doi:10.1016/j.schres.2013.08.005
39. Nakamura, K., Kawasaki, Y., Suzuki, M., Hagino, H., Kurokawa, K., Takahashi, T., et al. (2004). Multiple structural brain measures obtained by three-dimensional magnetic resonance imaging to distinguish between schizophrenia patients and normal subjects. Schizophr. Bull. 30, 393-404. doi:10.1093/oxfordjournals.schbul.a007087
40. Otten, L. J., Alain, C., and Picton, T. W. (2000). Effects of visual attentional load on auditory processing. Neuroreport 11, 875-880. doi:10.1097/00001756-200003200-00043
41. Ozgurdal, S., Gudlowski, Y., Witthaus, H., Kawohl, W., Uhl, I., Hauser, M., et al. (2008). Reduction of auditory event-related P300 amplitude in subjects with at-risk mental state for schizophrenia. Schizophr. Res. 105, 272-278. doi:10.1016/j.schres.2008.05.017
42. Perkins, D. O., Gu, H., Boteva, K., and Lieberman, J. A. (2005). Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am. J. Psychiatry 162, 1785-1804. doi:10.1176/appi.ajp.162.10.1785
43. Roth, W. T., Pfefferbaum, A., Horvath, T. B., Berger, P. A., and Kopell, B. S. (1980). P3 reduction in auditory evoked potentials of schizophrenics. Electroencephalogr. Clin. Neurophysiol. 49, 497-505. doi:10.1016/0013-4694(80)90392-2
44. Schroger, E., Giard, M. H., and Wolff, C. (2000). Auditory distraction: event-related potential and behavioral indices. Clin. Neurophysiol. 111, 1450-1460. doi:10.1016/S1388-2457(00)00337-0
45. Schroger, E., and Wolff, C. (1998). Attentional orienting and reorienting is indicated by human event-related brain potentials. Neuroreport 9, 3355-3358. doi:10.1097/00001756-199810260-00003
46. Shaikh, M., Valmaggia, L., Broome, M. R., Dutt, A., Lappin, J., Day, F., et al. (2012). Reduced mismatch negativity predates the onset of psychosis. Schizophr. Res. 134, 42-48. doi:10.1016/j.schres.2011.09.022
47. Sumiyoshi, T., Higuchi, Y., Itoh, T., Matsui, M., Arai, H., Suzuki, M., et al. (2009). Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a three-dimensional analysis with sloreta. Psychiatry Res. 172, 180-183. doi:10.1016/j.pscychresns.2008.07.005
48. Sumiyoshi, T., Higuchi, Y., Kawasaki, Y., Matsui, M., Kato, K., Yuuki, H., et al. (2006). Electrical brain activity and response to olanzapine in schizophrenia: a study with LORETA images of P300. Prog. Neuropsychopharmacol. Biol. Psychiatry 30, 1299-1303. doi:10.1016/j.pnpbp.2006.04.028
49. Sumiyoshi, T., Jayathilake, K., and Meltzer, H. Y. (2003). The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia. Schizophr. Res. 59, 7-16. doi:10.1016/S0920-9964(01)00329-2
50. Sumiyoshi, T., Miyanishi, T., Seo, T., and Higuchi, Y. (2013). Electrophysiological and neuropsychological predictors of conversion to schizophrenia in at-risk subjects. Front. Behav. Neurosci. 7:148. doi:10.3389/fnbeh.2013.00148
51. Takahashi, T., Zhou, S. Y., Nakamura, K., Tanino, R., Furuichi, A., Kido, M., et al. (2011). A follow-up MRI study of the fusiform gyrus and middle and inferior temporal gyri in schizophrenia spectrum. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 1957-1964. doi:10.1016/j.pnpbp.2011.07.009
52. Takayanagi, Y., Takahashi, T., Orikabe, L., Mozue, Y., Kawasaki, Y., Nakamura, K., et al. (2011). Classification of first-episode schizophrenia patients and healthy subjects by automated MRI measures of regional brain volume and cortical thickness. PLoS ONE 6:e21047. doi:10.1371/journal.pone.0021047
53. Umbricht, D., Javitt, D., Novak, G., Bates, J., Pollack, S., Lieberman, J., et al. (1998). Effects of clozapine on auditory event-related potentials in schizophrenia. Biol. Psychiatry 44, 716-725. doi:10.1016/S0006-3223(97)00524-6
54. Umbricht, D., and Krljes, S. (2005). Mismatch negativity in schizophrenia: a meta-analysis. Schizophr. Res. 76, 1-23. doi:10.1016/j.schres.2004.12.002
55. Yamazawa, R., Nemoto, T., Kobayashi, H., Chino, B., Kashima, H., and Mizuno, M. (2008). Association between duration of untreated psychosis, premorbid functioning, and cognitive performance and the outcome of first-episode schizophrenia in Japanese patients: prospective study. Aust. N. Z. J. Psychiatry 42, 159-165. doi:10.1080/00048670701787537
56. Yung, A. R., McGorry, P. D., McFarlane, C. A., Jackson, H. J., Patton, G. C., and Rakkar, A. (1996). Monitoring and care of young people at incipient risk of psychosis. Schizophr. Bull. 22, 283-303. doi:10.1093/schbul/22.2.353
57. Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S. M., McFarlane, C. A., Hallgren, M., et al. (2003). Psychosis prediction: 12-month follow up of a high-risk (prodromal) group. Schizophr. Res. 60, 21-32. doi:10.1016/S0920-9964(03)80061-0
58. Yung, A. R., Yuen, H. P., McGorry, P. D., Phillips, L. J., Kelly, D., Dell'Olio, M., et al. (2005). Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust. N. Z. J. Psychiatry 39, 964-971. doi:10.1080/j.1440-1614.2005.01714.x